Facilitated By

San Antonio Medical Foundation

Efficacy testing of a Pan-Ebolavirus Virus Monoclonal Antibody Medical Countermeasure (Sudan)

Texas Biomedical Research Institute

 

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Carrion, Ricardo
Collaborating Institutions
Mapp Biopharmaceutical
Inc.
Funded by
Biomedical Advanced Research and Development Authority
Research Start Date
Status
Active

The Major goal is to test efficacy of novel monoclonal therapeutic in the Sudan virus NHP Model.

Collaborative Project
Drug Discovery
Infectious Disease